Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dynavax Technologies (NQ: DVAX )

9.430 -0.300 (-3.08%)
Streaming Delayed Price Updated: 12:42 PM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,074,608
Open 9.400
Bid (Size) 9.430 (9)
Ask (Size) 9.440 (8)
Prev. Close 9.730
Today's Range 9.270 - 9.640
52wk Range 7.260 - 21.39
Shares Outstanding 124,921,757
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
110 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. 
Via Benzinga
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
Via Benzinga

Performance

YTD
-32.06%
-32.06%
1 Month
-8.09%
-8.09%
3 Month
-29.20%
-29.20%
6 Month
-45.05%
-45.05%
1 Year
+21.52%
+21.52%

More News

Read More
56 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action
Via Benzinga
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
Via FinancialNewsMedia
Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron
Via Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Via Benzinga
Recap: Dynavax Technologies Q4 Earnings
Via Benzinga
A Preview Of Dynavax Technologies's Earnings
Via Benzinga
Three doses of Valneva's COVID-19 Vaccine Neutralizes Omicron Variant, Lab Study Shows
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Via Benzinga
Here's Why These 3 COVID-19 Vaccine Stocks Got Crushed This Week
Via The Motley Fool
Exposures COVID-19
Why Dynavax Stock Is Tumbling Today
Via The Motley Fool
Why Are Valneva Shares Trading Higher Today?
Via Benzinga
2 Top Stocks You Can Still Buy for Under $20 a Share
Via The Motley Fool
Valneva Shares Soar On Securing EU COVID-19 Vaccine Deal
Via Benzinga
Exposures COVID-19
Why Dynavax Stock Is Falling Today
Via The Motley Fool
92 Biggest Movers From Friday
Via Benzinga
64 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dynavax Technologies (DVAX) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
28 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Will Valneva and Dynavax Score With Their Late-to-the-Party COVID Vaccine?
Via The Motley Fool
Exposures COVID-19
Why Shares of Dynavax Technologies, Ocugen, and Valneva Are on the Move Today
Via The Motley Fool
Exposures COVID-19
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
Via FinancialNewsMedia
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.